Sunil Prabhu, BPharm, PhD
Dean and Professor, Biotechnology and Pharmaceutical Sciences
College of Pharmacy
Management Development Program, Harvard Graduate School of Education (HGSE), June 2023
Academic Leadership Certification, Haas School of Business, University of California, Berkeley, 2012
AACP Fellow, Academic Leaders Fellowship Program (ALFP), 2009
Doctor of Philosophy (PhD), Pharmaceutics, 1996
West Virginia University, Morgantown, WV
Bachelor of Pharmacy (B.Pharm)1987
Birla Institute of Technology, India
Formulation development of novel drug delivery systems; application of nanotechnology
for controlled release system design; cancer chemoprevention; targeted therapy.
Principal Investigator, “Combinatorial nanotechnology-based regimens for pancreatic cancer chemoprevention” NIH, National Cancer Institute (NCI), R15 program, 2014-2017.
Principal Investigator, “Chemoprevention of pancreatic cancer using a combinatorial nano-drug system” NIH, National Cancer Institute (NCI), R03 program, 2011-2013.
Principal Investigator, "Combined Chemoprevention Using A Nanotechnology-based Therapeutic System", NIH, National Cancer Institute (NCI), R03 Program, 2007- 2010.
- Preshita Desai1*, Katherine Bang1, Jeffrey Wang1, Patrick Chan1, Donald Hsu1, Micah Hata1, and Sunil Prabhu1*3-Dimensional Printing for Precision and Personalized Patient Care: A New Paradigm for Pharmacy Practice? Pharmaceutics2026, 18(2),158; https://doi.org/10.3390/pharmaceutics18020158
- Desai P*,Bang K,Chowdhury M, Wang Z,Wang J, Prabhu S, Xuequin L, Kassie F. Development, Optimization, and Evaluation of Nano Self-Emulsifying Drug Delivery System Formulation Platform for Oral Bioavailability Enhancement of Sulfasalazine and Disulfiram in Lung Cancer Chemoprevention. PharmRes(2025). https://doi.org/10.1007/s11095-025-03964-7
- Kassie, F., Wang, K.,Bang, K.,Chowdhury, M. R. H.,Wang, J., Prabhu, S., Liang, X., Seelig, D.,Desai, P.(2025). Lung cancer chemo-interception by sulfasalazine and disulfiram codelivered using a nano self-emulsifying drug delivery system in mice. Carcinogenesis, 46(4), bgaf075. https://doi.org/10.1093/carcin/bgaf075
- Desai P, Prabhu S. Self-assembling nanoparticles: A novel approach for targeted cancer treatment using tumor treating fields. Cancer Res.2022;82(12):299.
- Desai P, Prabhu S. Drug-loaded nanoparticle targeting of pancreatic cancer using tumor treating fields (TTFields). Cancer Res. 2021;81(13):LB023.
- Wagh P, Desai P, Wang J, Prabhu S. Nanotechnology-based celastrol formulations and their therapeutic applications. Front Pharmacol. 2021;12:673209.
- Zhan S, Paik A, Onyeabor F, Ding B, Prabhu S, Wang J. Oral bioavailability evaluation of celastrol-encapsulated silk fibroin nanoparticles using an optimized LC-MS/MS method. Molecules.2020;25(15):3422.
- Desai P, Thumma N, Wagh PR, Zhan S, Ann DK, Wang J, Prabhu S. Cancer chemoprevention using nanotechnology-based approaches. Front Pharmacol. 2020;11:323.
- Desai P, Wang KZ, Ann D, Wang J, Prabhu S. Efficacy and pharmacokinetic considerations of loratadine nanoformulations and its combinations for pancreatic cancer chemoprevention. Pharm Res.2020;37(2):21.